XML 15 R70.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Financial Information (Details 4) (USD $)
In Thousands, unless otherwise specified
0 Months Ended 6 Months Ended
May 16, 2014
Mar. 28, 2014
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:        
Net cash provided by (used in) continuing operations     $ 120,137 $ 75,095
Net cash provided by discontinued operations     2,466 5,520
Net cash provided by operating activities     122,603 80,615
Cash flows from investing activities:        
Capital expenditures     (238,210) (214,934)
Proceeds from sale of property, plant and equipment     13,399 71,111
Payment for MidCon acquisition     (360,521)  
Increase in restricted cash     (245)  
Return of investments in non-consolidated affiliates     9,799 9,387
Cash invested in non-consolidated affiliates     (197)  
Net cash used in continuing operations     (575,975) (134,436)
Net cash provided by discontinued operations     33,276 29,335
Net cash used in investing activities     (542,699) (105,101)
Cash flows from financing activities:        
Proceeds from borrowings of long-term debt     1,389,799 1,474,037
Repayments of long-term debt     (1,051,000) (1,407,750)
Payments for debt issuance costs     (6,923) (11,929)
Payments above face value for redemption of convertible debt     (15,007)  
Payments for settlement of interest rate swaps that include financing elements     (1,894) (314)
Net proceeds from the sale of Partnership units     169,471  
Proceeds from stock options exercised     10,767 5,789
Proceeds from stock issued pursuant to our employee stock purchase plan     897 805
Purchases of treasury stock     (6,315) (3,515)
Dividends to Exterran stockholders (10,000) (10,000) (19,990)  
Stock-based compensation excess tax benefit     7,820 1,026
Distributions to noncontrolling partners in the Partnership     (35,291) (30,679)
Net cash provided by financing activities     442,334 27,470
Effect of exchange rate changes on cash and cash equivalents     (4,000) (644)
Net increase in cash and cash equivalents     18,238 2,340
Cash and cash equivalents at beginning of period     35,665 34,601
Cash and cash equivalents at end of period     53,903 36,941
Eliminations
       
Cash flows from investing activities:        
Capital expenditures       3,378
Proceeds from sale of property, plant and equipment       (3,378)
Capital distributions received from consolidated subsidiaries     (26,641) (20,250)
Investment in consolidated subsidiaries     11,128 9,454
Return of investments in consolidated subsidiaries     (252,482)  
Net cash used in continuing operations     (267,995) (10,796)
Net cash used in investing activities     (267,995) (10,796)
Cash flows from financing activities:        
Distributions to noncontrolling partners in the Partnership     26,641 20,250
Net proceeds from sale of general partner units     (3,573)  
Capital distributions to affiliates     252,482  
Capital contributions received from parent     (7,555) (9,454)
Net cash provided by financing activities     267,995 10,796
Parent | Reportable Legal Entities
       
Cash flows from operating activities:        
Net cash provided by (used in) continuing operations     (7,624) (3,235)
Net cash provided by operating activities     (7,624) (3,235)
Cash flows from investing activities:        
Return of investments in consolidated subsidiaries     252,482  
Net cash used in continuing operations     252,482  
Net cash used in investing activities     252,482  
Cash flows from financing activities:        
Proceeds from borrowings of long-term debt     825,001 631,501
Repayments of long-term debt     (769,500) (599,250)
Payments above face value for redemption of convertible debt     (15,007)  
Proceeds from stock options exercised     10,767 5,789
Proceeds from stock issued pursuant to our employee stock purchase plan     897 805
Purchases of treasury stock     (6,315) (3,515)
Dividends to Exterran stockholders     (19,990)  
Stock-based compensation excess tax benefit     7,820 1,026
Borrowings (repayments) between consolidated subsidiaries, net     (278,461) (33,107)
Net cash provided by financing activities     (244,788) 3,249
Net increase in cash and cash equivalents     70 14
Cash and cash equivalents at beginning of period     11 24
Cash and cash equivalents at end of period     81 38
Guarantor Subsidiaries | Reportable Legal Entities
       
Cash flows from operating activities:        
Net cash provided by (used in) continuing operations     20,896 40,425
Net cash provided by operating activities     20,896 40,425
Cash flows from investing activities:        
Capital expenditures     (69,033) (115,664)
Proceeds from sale of property, plant and equipment     7,271 16,934
Payment for MidCon acquisition     (9,400)  
Capital distributions received from consolidated subsidiaries     26,641 20,250
Investment in consolidated subsidiaries     (11,128) (9,454)
Net cash used in continuing operations     (55,649) (87,934)
Net cash used in investing activities     (55,649) (87,934)
Cash flows from financing activities:        
Capital distributions to affiliates     (252,482)  
Borrowings (repayments) between consolidated subsidiaries, net     295,227 39,726
Net cash provided by financing activities     42,745 39,726
Net increase in cash and cash equivalents     7,992 (7,783)
Cash and cash equivalents at beginning of period     1,554 10,461
Cash and cash equivalents at end of period     9,546 2,678
Other Subsidiaries | Reportable Legal Entities
       
Cash flows from operating activities:        
Net cash provided by (used in) continuing operations     106,865 37,905
Net cash provided by discontinued operations     2,466 5,520
Net cash provided by operating activities     109,331 43,425
Cash flows from investing activities:        
Capital expenditures     (169,177) (102,648)
Proceeds from sale of property, plant and equipment     6,128 57,555
Payment for MidCon acquisition     (351,121)  
Increase in restricted cash     (245)  
Return of investments in non-consolidated affiliates     9,799 9,387
Cash invested in non-consolidated affiliates     (197)  
Net cash used in continuing operations     (504,813) (35,706)
Net cash provided by discontinued operations     33,276 29,335
Net cash used in investing activities     (471,537) (6,371)
Cash flows from financing activities:        
Proceeds from borrowings of long-term debt     564,798 842,536
Repayments of long-term debt     (281,500) (808,500)
Payments for debt issuance costs     (6,923) (11,929)
Payments for settlement of interest rate swaps that include financing elements     (1,894) (314)
Net proceeds from the sale of Partnership units     169,471  
Distributions to noncontrolling partners in the Partnership     (61,932) (50,929)
Net proceeds from sale of general partner units     3,573  
Capital contributions received from parent     7,555 9,454
Borrowings (repayments) between consolidated subsidiaries, net     (16,766) (6,619)
Net cash provided by financing activities     376,382 (26,301)
Effect of exchange rate changes on cash and cash equivalents     (4,000) (644)
Net increase in cash and cash equivalents     10,176 10,109
Cash and cash equivalents at beginning of period     34,100 24,116
Cash and cash equivalents at end of period     $ 44,276 $ 34,225